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Abstract
Background and objectives: delirium is a distressing but potentially preventable condition common in older people in long-
term care. It is associated with increased morbidity, mortality, functional decline, hospitalization and signiﬁcant healthcare
costs. Multicomponent interventions, addressing delirium risk factors, have been shown to reduce delirium by one-third in
hospitals. It is not known whether this approach is also effective in long-term care. In previous work, we designed a bespoke
delirium prevention intervention, called ‘Stop Delirium!’ In preparation for a deﬁnitive trial of Stop Delirium, we sought to
address key aspects of trial design for the particular circumstances of care homes.
Design: a cluster randomized feasibility study with an embedded process evaluation.
Setting and participants: residents of 14 care homes for older people in one metropolitan district in the UK.
Intervention: Stop Delirium!: a 16-month-enhanced educational package to support care home staff to address key delirium
risk factors. Control homes received usual care.
Measurements: we collected data to determine the following: recruitment and attrition; delirium rates and variability between
homes; feasibility of measuring delirium, resource use, quality of life, hospital admissions and falls; and intervention implemen-
tation and adherence.
Results: two-thirds (215) of eligible care home residents were recruited. One-month delirium prevalence was 4.0% in interven-
tion and 7.1% in control homes. Proposed outcome measurements were feasible, although our approach appeared to under-
estimate delirium. Health economic evaluation was feasible using routinely collected data.
Conclusion: a deﬁnitive trial of delirium prevention in long-term care is needed but will require some further design modiﬁca-
tions and pilot work.
Keywords: delirium, long-term care, prevention, cluster randomized trial, older people
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Introduction
Delirium is a distressing but potentially preventable condi-
tion common in older people. It is associated with increased
morbidity, mortality, functional decline, hospitalization and
signiﬁcant healthcare costs [1–3].
Most delirium research has focussed on hospital
patients. Another expanding group [4], for whom the
burden of delirium is likely to be considerable, is residents
of care homes, with a clustering of delirium risk factors [5],
especially older age and dementia [6, 7]. We use the term
‘care home’ to refer to all residential long-term care settings
providing group living and personal and/or nursing care
for older people.
Delirium point prevalence in the care home population
has been estimated to be 14% [8], and 33% for residents
with advanced dementia [9]. Multicomponent interventions
that target modiﬁable risk factors have been shown to reduce
delirium by approximately one-third in hospitals [10–12].
These are areas of care that should be equally applicable to
long-term care settings, but the effectiveness of delirium pre-
vention in care homes is not yet known [13].
Delirium has been linked to quality of care [3, 14]. A
focus on delirium prevention may, therefore, present an op-
portunity not only to reduce delirium but also to improve
quality of care for older people living in care homes, with po-
tential additional beneﬁts that include reducing morbidity,
hospital admissions and healthcare costs. The NICE
Delirium guideline, therefore, includes a research recommen-
dation to develop such evidence [13].
In previous work, we used the UK Medical Research
Council framework for evaluating complex interventions
[15] to design an intervention to prevent delirium in care
homes (entitled Stop Delirium!) and demonstrated its feasi-
bility [16, 17]. ‘Stop Delirium!’ is an enhanced educational
package, incorporating additional strategies to change prac-
tice, designed to support staff to target common risk
factors for delirium in residents. The intervention has been
described in previous publications [17, 18], and materials
can be viewed on the European Delirium Association
website [19].
Building on this work, and to address key aspects of
future trial design and intervention implementation for the
particular circumstances of care homes, we report a feasibility
study to test and optimize the protocol for a deﬁnitive trial of
Stop Delirium! The speciﬁc objectives of the study were to
(i) estimate recruitment and attrition rates; (ii) estimate the
sample size for a subsequent trial with data on the proposed
primary outcome, delirium occurrence, its variability and the
intraclass coefﬁcient (ICC), and to report data on hospital
admission rates (as a potential alternative primary outcome);
(iii) explore feasibility of collecting proposed baseline and
outcome measures; (iv) test feasibility and reﬁne the strategy
for collecting resource use and quality-of-life data to inform
the health economics evaluation; and (v) assess implemen-
tation, adherence and sustainability of the Stop Delirium!
intervention.
Methods
A summary of methods is given here with full details avail-
able in the published protocol [18].
Design and setting
We conducted a parallel group, cluster randomized con-
trolled feasibility trial in 14 care homes providing care for
older people. Changes to the original protocol included the
introduction of a second phase of resident recruitment 12
months after randomization because of a high attrition rate,
and conducting structured case note reviews in order to
explore the possibility that reliance on face-to-face assess-
ments alone might be underestimating delirium.
Eligibility criteria
Independent sector care homes providing nursing or residen-
tial care for older people in one metropolitan district were
eligible. All residents were eligible unless they had severe
communication difﬁculties, were unable to communicate in
English or were receiving end-of-life care.
Outcomes
For the future deﬁnitive trial, the proposed primary outcome
is delirium occurrence. Delirium detection ideally requires
repeated daily assessments, which would be challenging in
multiple care homes. We therefore assessed the feasibility of
research staff detecting delirium during a single month, 16
months after randomization. Feasibility of collecting the fol-
lowing secondary outcomes was also examined: severity and
duration of delirium episodes; hospital admissions (number,
length of stay and time to ﬁrst admission), falls and mortality
during previous 6 months and the number of medications.
Sample size
The number of homes was determined to allow a maximum
range of homes within the research resources available to this
feasibility study.
Participant recruitment and consent
Informed, written consent was obtained from participants,
or for those lacking capacity to consent, agreement from a
relative or professional caregiver, following requirements of
the UK Mental Capacity Act, 2005 [20].
Randomization
Homes were randomized to intervention or control on a 1:1
basis using a computer-generated minimization programme
by the Leeds Clinical Trials Research Unit that stratiﬁed by
the size of the home in terms of the number of residents
(<20, ≥20) and percentage of residents with dementia
(<62%, ≥62%). Randomization took place after completion
of the ﬁrst phase of resident recruitment and baseline
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assessment. Thereafter, blinding of participants, staff or
researchers to allocation was not feasible given the nature of
the intervention and resource limitations.
Stop Delirium! intervention
The study intervention comprised a multifaceted enhanced
educational package incorporating multiple strategies to
change practice delivered to each care home over 16 months.
The intervention has been described in detail elsewhere [16–
19]; in brief, it consisted of a specialist Delirium Practitioner
(a mental health nurse with expertise in delirium and in pro-
viding interactive education and training) who delivered three
interactive education sessions and facilitated Working Groups
of care home staff. Working Groups identiﬁed targets for
delirium prevention and developed bespoke solutions for
each home. The Delirium Practitioner also trained a Delirium
Champion in each home. This was supported by a Delirium
Box containing resources designed to support learning and
act as reminders.
Control
Care homes randomized to be controls continued with care
as usual. Control homes were offered the Stop Delirium!
package after the end of the study, and all seven opted to im-
plement the intervention.
Data collection
At recruitment, resident demographics, medications, activ-
ities of daily living (ADL) (Barthel index [21]) and co-
morbidity (Charlson index [22]) were collected from care
home records. Tests for visual (Snellen test card), hearing
(Whisper test) and cognitive impairment (6-CIT [23]) were
conducted. Trained research assistants also assessed for delir-
ium using the short version Confusion Assessment Method
(CAM) [24] and, for those screening positive, the Delirium
Rating Scale-Revised-98 (DRS-R-98) [25]. Collateral infor-
mation to inform completion of the CAM was sought from
care home staff.
At follow-up, residents were assessed for delirium on al-
ternate days (except Sundays) over a 1-month period starting
16 months after randomization. Inter-rater reliability was
assessed by a second researcher observing the interview and
scoring the CAM independently. Delirium severity was
assessed using the DRS-R-98 (score >15.25) and duration
using the number of days CAM positive for each delirium
episode. Structured case note reviews were also undertaken
for the same 1-month period using an established method to
identify delirium cases [26].
Medications, hospital admissions, falls and deaths in a
6-month period starting 10 months after randomization were
collected for each resident from care home records. We also
obtained data for hospital admissions for the same 6-month
period from hospitals in the catchment area, both for individ-
ual consented residents, and by care home postcode. These
data are routinely collected by hospitals for ‘Hospital Episode
Statistics’ (HES), a data warehouse containing details of all
admissions, outpatient appointments and Accident and
Emergency department attendances at NHS hospitals in
England.
Economic evaluation
We explored the feasibility of a number of approaches to
capture resource use: care-home-level monthly diaries;
resident-level care home record review and hospital record
capture, including data obtained directly from hospitals or
through a request to the Health and Social Care Information
Centre (a provider of national NHS hospital data).
We administered the EQ-5D and EQ-5D proxy [27] and
Social Care Related Quality of Life (SCRQoL) [28] at base-
line and the EQ-5D and Dementia Quality of Life [29]
(DEMQOL and DEMOQOL proxy) at follow-up to test
alternative modes of capturing utility values for this popu-
lation. Utility is used to weight survival in the calculation
of quality-adjusted life years, the recommended outcome
measure used in cost-effectiveness analysis [30].
Records were kept of resources used in delivering the
intervention and conducting research assessments (staff
time). Unit ﬁnancial costs for health and social care resources
were obtained from national sources [Personal Social
Services Research Unit (PSSRU) Costs of Health and Social
Care, British National Formulary (BNF) and NHS reference
cost databases] and used to determine costs of the Stop
Delirium! intervention and costs for health and social care
use by participants.
Implementation, adherence and sustainability
of the intervention
A process evaluation was conducted alongside the trial,
using the Normalisation Process Theory Framework [31] to
describe the process of implementation, integration and
sustainability of the intervention and to identify barriers
and facilitators. Details of this will be reported in a separate
publication.
Analysis
Quantitative data were summarized using descriptive statis-
tics; analyses focussed mainly on conﬁdence interval estima-
tion rather than formal hypothesis testing. The ICC and its
conﬁdence interval were estimated for delirium occurrence
using data from the post-intervention period.
Although determining differences between groups was
not the main purpose in this feasibility study, we constructed
the Kaplan–Meier plots [32] for time to hospital admission
and mortality for the whole population and by study arm.
All analyses were conducted using Statistical Package for
the Social Sciences (SPSS) (BM Corp. Released 2013. IBM
SPSS Statistics for Windows, Version 22.0. Armonk, NY:
IBM Corp.) and R [R Core Team (2012). R: A language
and environment for statistical computing. R Foundation for
Statistical Computing, Version 2.15.2. Vienna, Austria. ISBN
3-900051-07-0, URL http://www.R-project.org/].
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The study was approved by an NHS Research Ethics
Committee (12/YH/0018).
Results
Recruitment and attrition
Figure 1 presents a CONSORT diagram of participant ﬂow
in the study.
The 14 participating care homes were of similar size to
homes that declined. Supplementary data, Appendix Table 1,
available in Age and Ageing online describes their size, resident
population and stafﬁng.
Out of 639 registered residents, 591 (92.4%) could be
screened for eligibility within the time available [463/486
(95.3%) in Phase 1 and 128/153 (83.7%) in Phase 2]; 340
(57.5%) were found to be eligible. The most common reason
for ineligibility was severe communication problems (166/
251, 63.4%), followed by end-of-life care (27/251, 10.3%).
Two-thirds (215/340) of eligible residents were recruited.
The recruitment rate was higher in residents with capacity
than without capacity [159/234 (67.9%; 95% CI: 61.9, 73.9)
and 56/103 (54.4%; 95% CI: 44.8, 64.0), respectively]. The
mean cluster size was 15.4 (SD 4.1). Supplementary data,
Appendix Table 2, available in Age and Ageing online describes
characteristics of all residents and of those recruited to the
study by recruitment phase and by allocation. There were dif-
ferences between allocation arms at baseline, with the Stop
Delirium! group having a higher proportion of residents who
were male, in nursing (as opposed to residential) care, lacking
capacity to consent and with a dementia diagnosis.
Attrition
Overall, the attrition rate was 38.1% (82/215) (Figure 1);
attrition was, as expected, higher among residents recruited
in Phase 1 [45.6% (73/160)] compared with those recruited
in Phase 2 [16.4% (29/55)] because of the longer interval
between recruitment and follow-up.
Sample size
Delirium occurrence
There were three cases of delirium identiﬁed in the 215 resi-
dents at recruitment, giving a point prevalence of 1.4%.
Over the 1-month follow-up period, there were 13
CAM-positive assessments (3 in the intervention and 10 in
the control arm). Consecutive positive assessments were
counted as a single episode. Delirium period prevalence was,
therefore, estimated as 4.0% (3/75 residents; 95% CI: 0, 8.4)
in intervention and 7.1% (6/85 residents; 95% CI: 1.6, 12.6)
in control homes. Delirium incidence was estimated as 4.9
(95% CI: 0.7, 15) per 100 resident-months at risk in interven-
tion homes and 7.9 (95% CI: 1.4, 22.0) per 100 resident-
months at risk in control homes (taking account of incomplete
follow-up due to withdrawal from the study or death part-way
through the month).
The DRS-R-98 was completed for 12 of the 13 instances
of CAM-positive assessments; all were rated as high severity.
Structured care home records reviews identiﬁed 23 resi-
dents with delirium from 130 records reviewed, 20.3% (14/
69) in intervention and 14.8% (9/61) in control homes. All
but one of the nine cases of delirium identiﬁed by the CAM
were also identiﬁed by case note review. In two homes,
records could not be accessed within the study period.
Intraclass coefficient
The ICC for the proposed primary outcome, the proportion
of residents with at least one CAM-positive assessment
during the 1-month follow-up period, was estimated as 0.04
(95% CI: −0.02, 0.2).
Sample size estimate
Using this ICC to estimate the design effect, an expected de-
lirium 1-month period prevalence of 15% in control and 8%
in intervention groups, and an average cluster size of 26, the
sample size for a deﬁnitive cluster trial is 36 homes (926 resi-
dents) per group to give 90% power at 95% signiﬁcance level
(two sided). The estimated delirium rate is taken from a
review of previous long-term care studies [8] and the cluster
size from the size of homes in a large national trial in care
homes currently underway [33], applying our recruitment
and attrition rates.
Hospital admission rates
At recruitment, using data obtained directly from hospitals,
the 6-month hospital admission rate per 100 residents was
54.1 (SD 38.6) in intervention and 56.2 (SD 33.0) in control
homes. At follow-up, the rates were 42.9 (SD 28.8) in inter-
vention and 64.2 (SD 26.3) in control homes. Figure 2 pre-
sents a Kaplan–Meier plot for time to hospital admission by
allocation arm, starting 10 months following randomization.
Other outcomemeasures
Medications
The mean number of medications per resident was 8.7 (SD
3.9) in the intervention and 9.1 (SD 3.9) in the control
homes at follow-up.
Deaths
In 215 residents recruited, there were 49 deaths by study
end, 20.4% (21/103) in intervention and 25% (28/112) in
control homes. A Kaplan–Meier plot gave no indication of
difference in survival at 16 months between the two study
arms (Figure 2).
Feasibility of baseline and outcomemeasurements
Baseline
High rates of completion were achieved for most assess-
ments (100% for Barthel index, Charlson index and the
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Figure 1. CONSORT diagram of ﬂow of participants through the trial.
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CAM; and more than 80% for cognitive and visual impair-
ment tests). However, only two-thirds of hearing tests were
conducted due to lack of appropriate space in the care home.
Delirium assessments
In total, 69.6% (1,389/1,996) of the planned CAM assess-
ments [66.7% (913/1,368) for those recruited in Phase 1 and
75.8% (476/628) in Phase 2] were conducted during the
1-month follow-up period. Supplementary data, Appendix
Table 3, available in Age and Ageing online summarizes assess-
ments and reasons for non-completion by randomization
group.
The inter-rater reliability for CAM was high (100%), al-
though only 20 paired assessments were conducted because
of limited researcher time. The DRS-R-98 could be used to
Figure 2. Time to hospital admission and mortality by randomization arm.
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assess delirium severity. Delirium duration, however, was dif-
ﬁcult to estimate. Alternate-day CAM assessments could not
differentiate between 1 and 3 days’ duration, and case note
entries were insufﬁciently precise to determine duration of
discrete delirium episodes.
Hospital admissions
Summary home-level data for hospital admissions (obtained
from care homes) were missing for two homes, and rates
were lower than estimated from other sources. Admissions
were recorded in individual resident records, but this was a
resource-intensive source, requiring individual consent from
participants.
Data obtained directly from hospitals were the most readily
accessible source of information for hospital admissions.
Falls
Recording of falls differed markedly with some homes
recording any instances where a resident was found on the
ﬂoor as a fall, and others limiting recording to observed falls
only; falls data were not, therefore, analysed further.
Resources for research assessments
Recruitment and conduct of baseline assessments required
two full-time researchers for 7 months, with a similar re-
quirement for outcome assessments.
Health economics
Health and social care resource use
Resident-level data collection diaries were found not to be
feasible for completion by residents and too burdensome for
staff. Care-home-level diaries were also only partially com-
pleted by staff due to time pressures. It was uncommon for
friends and family members to be either present to complete
proxy forms or to have spent sufﬁcient time observing the
resident to be able to comment.
We were unable to obtain a timely response to the request
for Health and Social Care Information Centre data because
of an embargo in place at the time. However, we were able to
conﬁrm that the data requested in our application were avail-
able from the centre. Data obtained directly from hospitals
offered a robust way of capturing secondary care resource
use. Using these, the overall cost for residents in the inter-
vention arm was estimated as £3,281 and in the control
homes £7,210. In addition, there were lower monthly costs
per resident for homes in the intervention arm (£219.72
compared with £253.01, a saving of £33.29).
Quality of life
At baseline, the EQ-5D and SCRQoL were administered with
only 4 and 2%missing assessments, respectively. At follow-up,
non-completion rates for EQ-5D and DEMQoL-5D were
20 and 12%, respectively. However, there was a ceiling effect
(a high proportion of residents had ‘full health’) in both the
SCRQoL and DEMQoL limiting their usefulness. In addition,
the SCRQoL was prohibitively resource intensive in terms of
researcher time.
The mean EQ-5D score was similar at baseline for resi-
dents in intervention and control arms [0.50 (SD ± 0.40)
and 0.51 (SD ± 0.37), respectively] and as expected deterio-
rated over time in both [to 0.42 (SD ± 0.39) in intervention
and 0.38 (SD + 0.42) in control homes].
Stop Delirium! costs
The total cost of delivering Stop Delirium! was £138 per
care home resident, including costs for care home staff time
and for the Delirium Practitioner.
Given the difﬁculties with capturing resource use at a resi-
dent level, we were unable to estimate the costs for an
episode of delirium.
Intervention delivery
Overall, 84.4% of staff completed at least one education
session; in four homes, over 90% of staff completed all three
sessions. Working Groups were established in all homes.
A Delirium Champion was identiﬁed in four, and there was
evidence of outputs from Working Groups being used in ﬁve
out of the seven homes.
Delivery of the intervention was compromised in the later
part of the study due to ﬁrst sickness absence and then ma-
ternity leave of the Delirium Practitioner (9 out of 22
months).
Discussion
Our ﬁndings have a number of implications for delirium re-
search in care homes in general and speciﬁcally for a deﬁni-
tive trial of delirium prevention.
Study design
Our approach to recruitment was successful, securing re-
presentation of residents both with and without capacity in
the study sample. However, our selection criteria excluded
residents with severe communication difﬁculties because of
the nature of the study assessments, thus excluding some of
the very residents most vulnerable to delirium. Attrition was
high when there was a 16-month interval between recruit-
ment and follow-up. This is consistent with the reported
ﬁnding of a median survival rate of 12 months for nursing
and 16 months for residential care home residents [34]. A
cross-sectional design recruiting trial participants nearer to
follow-up could address this; we achieved a 96% follow-up
rate using this approach for participants recruited in Phase
2. Potential differential recruitment inﬂuenced by knowledge
of allocation could be addressed by blinding researchers
involved in recruitment, although maintaining blinding is
challenging with an intervention that is highly visible.
7
Preventing delirium in care homes
 at Edinburgh U
niversity on M
ay 30, 2016
http://ageing.oxfordjournals.org/
D
ow
nloaded from
 
Measuring delirium
Rates for delirium prevalence and incidence in this study
were lower than expected from previous research. It is pos-
sible that they are an underestimate of the true rate for a
number of reasons. First, although our inclusion criteria were
broad, as mentioned above, we excluded residents with
severe communication difﬁculties. Assessments required the
participation of residents, excluding those who were too
unwell or unwilling to be seen by a researcher. These groups
include the very people most likely to be at risk of delirium.
Second, our study population had a high prevalence of
dementia and pre-existing cognitive impairment. Diagnosing
delirium superimposed on dementia is challenging, even for
experienced clinicians [35]. Although researchers had under-
gone training in using the CAM, they were often reliant on
information from care home staff who tended to ascribe any
deterioration to the underlying dementia. We anticipated that
care home staff would have a good understanding of resi-
dents’ usual health state and be well placed to report changes.
However, this was frequently not the case because of high
staff turnover and limited handover of information between
shifts. Third, researchers were only able to assess residents
during the day, potentially missing changes that manifested
during the evening or night and making it more difﬁcult to
identify a ﬂuctuating course. As residents were only assessed
on alternate weekdays, there were potentially 4 days between
some assessments, which may have also missed episodes of
short duration.
Finally, it is also possible that the low observed delirium
rate may have been due to higher quality of care or inclusion
of residents at lower risk of delirium. However, our rates of
dementia and hospitalization were similar to those reported
in the published literature.
The view that our face-to-face assessments underesti-
mated delirium appeared to be supported by care home
records reviews, which identiﬁed additional cases of delirium.
A combination of interview and records review has been
recommended previously [36]. However, recording of delir-
ium by staff may itself be inﬂuenced by the intervention; care
home records reviews identiﬁed considerably more delirium
episodes in the intervention homes, despite a lower observed
rate from face-to-face assessments in the present study.
McCusker et al. in a multisite cohort of long-term care
residents found a substantial increase in the reported preva-
lence of delirium when care home nurse-observed symptoms
(structured interviews and care home records) were com-
bined with symptoms observed by research staff alone [37].
However, there is still the possibility that increased awareness
of delirium by staff as a result of the intervention may lead to
increased availability of such informant information, inﬂuen-
cing delirium detection.
An alternative approach would be to restrict outcome
assessments to those most at risk of delirium (i.e. those with
dementia or acutely unwell [38]) or to use ‘whole home’
assessments. Delirium screening instruments for use by non-
specialists have been developed [39, 40], which could be
administered by care home staff as part of routine care.
Using anonymized data from such measures in research
would also avoid the problem of excluding residents who are
unable to be assessed for reasons that may be related to their
delirium risk. However, the validity of these instruments in
the care home setting is yet to be established. Again, it is
likely that completion of such a measure by staff would be
inﬂuenced by the intervention, making differentiation
between intervention delivery and outcome measurement
difﬁcult.
Delirium detection in long-term care is challenging. Daily
review by an experienced clinician using operationalized diag-
nostic criteria is the ‘gold standard’ but would be prohibitively
resource intensive in a large trial. Daily CAM administration
by a researcher with information from care home staff using
structured interviews and review of care home records,
despite its limitations, may be the optimum approach. Training
and availability of supervision by experienced clinicians for re-
search staff conducting CAM assessments would be important
in view of the uncertainties in diagnosing delirium, particularly
in people with dementia.
Other outcomes
An alternative is to use acute hospital admission as a primary
outcome (as preventing delirium should reduce the need for
hospital admission). An additional attraction in a trial where
blinding is not possible is that hospital admission rates are
less likely to be affected by observer bias. We were readily
able to determine hospital admission rates for care home
residents using routine data. However, this approach which
relies on postcodes to identify admissions from care homes
may not be reliable as homes may share a postcode with
other private residences. In a study of hospital use by long-
term care residents, 69% of hospital admissions identiﬁed as
being from a care home using routine data were actually from
a nursing or residential home [41]. A feasible alternative is to
obtain hospital admission data directly from care homes, as
these are increasing collected routinely as part of required
reporting to commissioners.
The routinely collected hospital data also provide the
most promising route to assess secondary care resource use.
It is anticipated that data linkage with General Practice data-
sets will additionally provide primary care resource use in
future.
We found that tools to capture health state utility were
limited by lack of validity for the long-term care population.
The only tool speciﬁcally developed for use in this setting
(the SCRQoL) will probably not be practicable within the
resources available in a large trial. Given the NICE re-
commendations [30], future studies should incorporate the
EQ-5D. However, they should also consider additional mea-
sures such as the ICECAP-O (ICEpop CAPability measure
for Older people) [42, 43], for which there is a recent and
growing validation evidence in this group.
There were signiﬁcant challenges in conducting this feasi-
bility trial. Nevertheless, we were able to recruit residents suc-
cessfully and conduct baseline and outcome assessments to a
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relatively high level of completion. On the basis of this study,
we think that a future deﬁnitive trial is feasible but will
require some modiﬁcations to the trial design in light of ex-
perience gained in this study.
Key points
• Delirium is a distressing but potentially preventable condi-
tion common in older people in long-term care.
• Delirium is associated with increased morbidity, mortality,
functional decline, hospitalization and signiﬁcant healthcare
costs.
• Multicomponent interventions can prevent delirium in hos-
pitalized patients, but their effectiveness in long-term care
is not known.
• Detection of delirium in long-term care research is challen-
ging and resource intensive.
• Routine screening for delirium by care home staff may
offer a way forward but requires further validation studies.
Supplementary data
Supplementary data mentioned in the text are available to
subscribers in Age and Ageing online.
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